Volume 25, Number 2—February 2019
Dispatch
Clinical Manifestations, Antimicrobial Drug Susceptibility Patterns, and Outcomes in Melioidosis Cases, India
Maria Koshy, Manjeera Jagannati, Ravikar Ralph, Punitha Victor, Thambu David, Sowmya Sathyendra, Balaji Veeraraghavan, and George M. Varghese
Table 2
Bivariate analysis of predictors of mortality from melioidosis, southern India, 2008–2014
| Predictors of mortality | Alive, n = 97 | Dead, n = 17 | Odds ratio (95% CI) | p value |
|---|---|---|---|---|
| Diabetes mellitus | 79 | 14 | 0.94 (0.23–3.62) | 0.92 |
| Harmful ethanol use | 14 | 2 | 0.90 (0.18–4.43) | 0.89 |
| Chronic kidney disease | 3 | 1 | 0.45 (0.04–4.65) | 0.5 |
| Tachypnea, reference >24/min | 12 | 12 | 16.8 (5.03–53.11) | <0.001 |
| Tachycardia, reference >100/min | 22 | 11 | 6.16 (2.04–18.57) | 0.001 |
| Hypotension, reference <90/60 mmHg | 4 | 7 | 16.10 (4.00–64.70) | <0.001 |
| Sequential organ failure assessment score | 1 (0–3) | 4 (2–8) | 1.4 (1.1–1.7) | <0.001 |
| Bacteremia | 47 | 16 | 17.02 (2.17–133.43) | 0.007 |
| Respiratory involvement | 19 | 9 | 4.61 (1.57–13.55) | 0.005 |
| Hypoalbuminemia, reference <3 g/dL | 38 | 13 | 4.02 (1.21–13.33) | 0.02 |
| Intensive care unit admission | 12 | 13 | 23.02 (6.44–82.24) | <0.001 |
| Mechanical ventilation | 8 | 13 | 36.15 (9.52–137.23) | <0.001 |
Page created: January 18, 2019
Page updated: January 18, 2019
Page reviewed: January 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.